Cargando…

Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia

Monocyte chemoattractant protein (MCP)-1 increases in the serum of immunocompetent patients with community-acquired pneumonia (CAP). However, the correlation between the circulating level of MCP-1 and severity of CAP remains unclear. This study investigated differential changes in the plasma MCP-1 l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yong, Kok-Khun, Chang, Jer-Hwa, Chien, Ming-Hsien, Tsao, Shih-Ming, Yu, Ming-Chih, Bai, Kuan-Jen, Tsao, Thomas Chang-Yao, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783913/ https://www.ncbi.nlm.nih.gov/pubmed/26840299 http://dx.doi.org/10.3390/ijms17020179

Ejemplares similares

Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia
por: Chang, Jer-Hwa, et al.
Publicado: (2016)

Monocyte Chemoattractant Protein-1, a Possible Biomarker of Multiorgan Failure and Mortality in Ventilator-Associated Pneumonia
por: Li, Yia-Ting, et al.
Publicado: (2019)

Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia
por: Tsai, Ping-Kun, et al.
Publicado: (2019)

Association of EGFR mutations and HMGB1 genetic polymorphisms in lung adenocarcinoma patients
por: Wu, Yi-Liang, et al.
Publicado: (2019)

Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia
por: Hsu, Shih-Chang, et al.
Publicado: (2019)

Associations of TIMP-3 Genetic Polymorphisms with EGFR Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients
por: Chang, Jer-Hwa, et al.
Publicado: (2020)

Circulating level of high mobility group box-1 predicts the severity of community-acquired pneumonia: Regulation of inflammatory responses via the c-Jun N-terminal signaling pathway in macrophages
por: Wang, Hsiang-Ling, et al.
Publicado: (2017)

Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c
por: Lien, Ming-Yu, et al.
Publicado: (2020)

New markers in pneumonia
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan
por: Huang, Yi-Wen, et al.
Publicado: (2016)

Monocyte chemoattractant protein-1 affects migration of hippocampal neural progenitors following status epilepticus in rats
por: Hung, Yu-Wen, et al.
Publicado: (2013)

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
por: Shen, Gwan-Han, et al.
Publicado: (2012)

The clinical efficacy of lefamulin in the treatment of elderly patients with community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020)

The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma
por: Wang, Yao-Chen, et al.
Publicado: (2021)

Predictors of Viral Pneumonia in Patients with Community-Acquired Pneumonia
por: Kim, Ji Eun, et al.
Publicado: (2014)

Genetic Variants of lncRNA MALAT1 Exert Diverse Impacts on the Risk and Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma
por: Yuan, Lan-Ting, et al.
Publicado: (2019)

792 Predictors of viral pneumonia in patients with community-acquired pneumonia
por: Kim, Ji Eun, et al.
Publicado: (2014)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

The Therapeutic Role of Monocyte Chemoattractant Protein-1 in a Renal Tissue Engineering Strategy for Diabetic Patients
por: Yin, Hao, et al.
Publicado: (2013)

Maintenance interferon therapy in chronic hepatitis C patients who failed initial antiviral therapy: A meta-analysis
por: Hung, Hung-Chang, et al.
Publicado: (2019)

Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study
por: Lee, Ming-Chia, et al.
Publicado: (2015)

Treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma: A meta-analysis
por: Li, Chien-Feng, et al.
Publicado: (2020)

Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2020)

Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder
por: Farhan, Bilal, et al.
Publicado: (2019)

Association of Carbonic Anhydrase 9 Polymorphism and the Epithelial Growth Factor Receptor Mutations in Lung Adenocarcinoma Patients
por: Yu, Ya-Yen, et al.
Publicado: (2020)

Elevated Plasma Stromal-Cell-Derived Factor-1 Protein Levels Correlate with Severity in Patients with Community-Acquired Pneumonia
por: Tsai, Ping-Kun, et al.
Publicado: (2014)

A functional promoter polymorphism in monocyte chemoattractant protein–1 is associated with increased susceptibility to pulmonary tuberculosis
por: Flores-Villanueva, Pedro O., et al.
Publicado: (2005)

Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma
por: Liu, Ju-Fang, et al.
Publicado: (2020)

Characteristics and local risk factors of community-acquired and health-care-associated Staphylococcus aureus pneumonia
por: Lee, Li-Na, et al.
Publicado: (2022)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

The RET–Glial Cell-derived Neurotrophic Factor (GDNF) Pathway Stimulates Migration and Chemoattraction of Epithelial Cells
por: Tang, Ming-Jer, et al.
Publicado: (1998)

FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan
por: Li, Ju-Pi, et al.
Publicado: (2020)

The Curcumin Analogue, EF-24, Triggers p38 MAPK-Mediated Apoptotic Cell Death via Inducing PP2A-Modulated ERK Deactivation in Human Acute Myeloid Leukemia Cells
por: Hsiao, Pei-Ching, et al.
Publicado: (2020)

Characteristics and etiology of hospitalized pediatric community-acquired pneumonia in Taiwan
por: Chi, Hsin, et al.
Publicado: (2020)

Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells
por: Chao, Hung-Hsing, et al.
Publicado: (2017)

The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance
por: Weng, Meng-Shih, et al.
Publicado: (2018)

Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer
por: Lin, Chang-Sheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9lc6omsu7onh10u9p2qbsijm3s